Find information on thousands of medical conditions and prescription drugs.

Itraconazole


Itraconazole (marketed as Sporanox® by Janssen Pharmaceutica) is an antifungal agent that is prescribed to patients with fungal infections. The drug may be given orally or intravenously. more...

Home
Diseases
Medicines
A
B
C
D
E
F
G
H
I
Ibuprofen
Idarubicin
Idebenone
IFEX
Iloprost
Imatinib mesylate
Imdur
Imipenem
Imipramine
Imiquimod
Imitrex
Imodium
Indahexal
Indapamide
Inderal
Indocin
Indometacin
Infliximab
INH
Inosine
Intal
Interferon gamma
Intralipid
Invanz
Invirase
Iontocaine
Iotrolan
Ipratropium bromide
Iproniazid
Irbesartan
Iressa
Irinotecan
Isocarboxazid
Isoflurane
Isohexal
Isoleucine
Isomonit
Isoniazid
Isoprenaline
Isordil
Isosorbide
Isosorbide dinitrate
Isosorbide mononitrate
Isotretinoin
Itraconazole
Ivermectin
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Pharmacology

The mechanism of action of itraconazole is the same as the other azole antifungals: it inhibits cytochrome P450 oxidase mediated sysnthesis of ergosterol.

Indication

Itraconazole has a broader spectrum of activity than fluconazole (but not as broad as voriconazole or posaconazole). In particular, it is active against aspergillus, which fluconazole is not. It is also licenced for use in blastomycosis, histoplasmosis and onychomycosis.

Dosing

Itraconazole is available as capsules or as an oral solution. The dose is 200mg once a day, to 400mg in severe infection. There is an intravenous preparation available in the US, but not in the UK. In the UK, if an intravenous preparation is required, then an alternative antifungal drug should be used.

The main problem with the use of itraconazole is its poor absorption, especially when given in capsule form. The oral solution is much better absorbed and should always be used in preference to the capsule. The cyclodextrin contained in the oral solution can cause an osmotic diarrhoea, and if this is a problem, then half the dose can be given as oral solution and half as capsule in order to reduce the amount of cyclodextrin given. Itraconazole capsules should always be taken with food, as this improves absorption. Itraconazole oral solution should be taken an hour before food, or two hours after food (and likewise if a combination of capsules and oral solution are used). Itraconazole should be taken with orange juice or cola, as absorption is also improved by acid. Absorption of itraconazole is impaired when taken with an antacid, H2-blocker or proton pump inhibitor.

In life-threatening situations, some doctors give an oral loading dose of 200mg three times a day for three days, before dropping down to the usual dose. Because itraconazole absorption is unreliable, blood levels should be monitored at least once a week in those patients who are being treated for life-threatening (or potentially life-threatening) fungal infections.

In intravenous dosing, four doses of itraconazole 200mg are given 12 hours apart, before changing the dose to once daily. There is no safety data for giving the intravenous preparation for more than 14 days continuously.

Adverse effects

Itraconazole is a relatively well tolerated drug (although not as well tolerated as fluconazole or voriconazole) and the range of adverse effects it produces is similar to the other azole antifungals.

  • Elevated alanine aminotransferase levels is found in 4% of people taking itraconazole
  • Congestive Heart Failure

The cyclodextrin that is used to make the syrup preparation can cause diarrhoea.

Read more at Wikipedia.org


[List your site here Free!]


PRODUCTION OF TUMOR NECROSIS FACTOR ALPHA AND INTERLEUKIN-6 BY HUMAN MONOCYTES STIMULATED IN VITRO WITH PARACOCCIDIOIDES BRASILIENSIS TREATED WITH AMPHOTERICIN
From Revista do Instituto de Medicina Tropical de Sao Paulo, 10/1/05 by Nakaira, E T

Nakaira, E. T.1; Sugizaki, M. F.2; Soares, A. M. V. C.3; Nascimento, M. P. P.4; Martins, R. A. R.5; Peraçoli, M. T. S.6

1,2,3,4,5,6IB - UNESP - Botucatu - Microbiologia e Imunologia

Introduction and Objectives: Monocytes from patients with paracoccidioidomycosis are important source of pro-inflammatory cytokines, such as tumor necrosis factor alpha (TNF-α), interleukin-1 (IL-1). and IL-6, that may be associated with the pathogenesis of the mycosis. On the other hand, the disease treatment with antifungal ats led to fungal load diminution, being a promising option for the control of paracoccidioidomycosis. The present work aimed to evaluate TNF-α and IL-6 production by human monocytes, in vitro stimulated by yeast-like form cells of Paracoccidioides brasiliensis, previously submitted to the treatment with amphotericin B (amph B) or itraconazole (itra). Methods and Results:Peripheral blood monocytes obtained from healthy individuals were in vitro cultured for 18 h at 37°C with suspensions of P. brasiliensis viable yeast cells (Pbv), yeast cells killed by autoclaving (Pbaut), viable cells treated for 10 min with amph B (Pbamph-10), or with itra (Pbitra-10), yeast cells killed by amph B treatment for 36 h with the minimun fungicidal concentration of amph B (Pbamph-36) or yeast cells treated for 72 h with the minimum inhibitory concentration of itra (Pbitra-72), in the ratios of 1:1 and 1:50 fungus-monocytes. The supematants obtained from these cultures were employed for TNF-α and IL-6 determination by enzyme immunoassay (ELISA). The results showed that human monocytes in vitro cultured with Pbv, or Pbaut release significantly higher levels of TNF-α and IL-6 in comparison with monocytes not stimulated with the fungus (control). Preincubation if Pb with amph B ou itra does not reduce cytokine levels produced by monocytes when the fungus:monocyte ratio is 1:1. The lower production of TNF-α by monocytes stimulated, with Pbv, Pbaut, or Pbitra obtained in the 1:50 fungus:monocyte ratio, suggests that TNF-α release depends on the concentration of fungal cells components. The high levels of IL-6 produced by monocytes stimulated with yeast-like cells of P. brasiliensis in the fungus:monocyte ratios of 1:1 and 1:50, suggest that low concentration of cell wall components are enough to induce this cytokine production. Conclusion: The results suggest that cell wall components of P. brasiliensis may be responsible for the induction of the inflammatory cytokines by monocytes. The high concentration of TNF-α produced by monocytes stimulated with Pbamph both at fungus:monocyte ratio of 1:1 and 1:50, indicate that amph B exerts modulatory effect on TNF-α production by monocytes. Financial support: FAPESP no. 02/12462-4 and no. 03/ 13743-0

Copyright Instituto de Medicina Tropical de Sao Paulo Oct 2005
Provided by ProQuest Information and Learning Company. All rights Reserved

Return to Itraconazole
Home Contact Resources Exchange Links ebay